AUROLAB
AURO LABORATORIES LTD.Healthcare
LTP
251.15
CHG · %
+0 (+0.00%)
VOL · TODAY
—
PREV CLOSE
251.15
Today's range0 · 0
251.15
52-week range0 · 317
251.15
Loading candles…
Auro Laboratories Ltd, incorporated in 1989, is an India-based pharmaceutical company operating within the pharmaceutical and healthcare industries. The company specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates, focusing particularly on bulk drugs. Its product portfolio includes anti-diabetic agents, muscle relaxant agents, antihistamine agents, and notably Metformin Hydrochloride, a key medication for type 2 diabetes management. Auro Laboratories Ltd serves both domestic Indian and international markets. The company does not have any listed subsidiaries or ventures and is not listed on any stock exchange. No information about founders or key management is provided.
AUROLAB is not part of any active scan today.
This page is a live market overview for AURO LABORATORIES LTD. (AUROLAB) on the BSE. As a listed security, AURO LABORATORIES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AUROLAB before placing trades on tick2trade.
As of the latest feed, AUROLAB last traded at ₹251.15 on BSE, up ₹0 (0.00%) from the previous close of ₹251.15. Today's session range is ₹0 – ₹0, against a 52-week band of ₹0 – ₹317. Traded volume today stands at — shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for AUROLAB in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AUROLAB is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AURO LABORATORIES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AUROLAB. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AUROLAB option chain page linked from this overview.
// similar in healthcare323 total